Cargando…
Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
BACKGROUND: Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark (90)Y RNT (at different dose rates) against external beam radiotherapy (...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119681/ https://www.ncbi.nlm.nih.gov/pubmed/30175390 http://dx.doi.org/10.1186/s40658-018-0217-8 |
_version_ | 1783352110115454976 |
---|---|
author | Gholami, Yaser H. Willowson, Kathy P. Forwood, Nicholas J. Harvie, Rozelle Hardcastle, Nicholas Bromley, Regina Ryu, HyunJu Yuen, Samuel Howell, Viive M. Kuncic, Zdenka Bailey, Dale L. |
author_facet | Gholami, Yaser H. Willowson, Kathy P. Forwood, Nicholas J. Harvie, Rozelle Hardcastle, Nicholas Bromley, Regina Ryu, HyunJu Yuen, Samuel Howell, Viive M. Kuncic, Zdenka Bailey, Dale L. |
author_sort | Gholami, Yaser H. |
collection | PubMed |
description | BACKGROUND: Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark (90)Y RNT (at different dose rates) against external beam radiotherapy (EBRT) in vitro and compare cell kill responses between the two irradiation processes. RESULTS: Three human colorectal carcinoma (CRC) cell lines (HT29, HCT116, SW48) were exposed to (90)Y doses in the ranges 1–10.4 and 6.2–62.3 Gy with initial dose rates of 0.013–0.13 Gy/hr (low dose rate, LDR) and 0.077–0.77 Gy/hr (high dose rate, HDR), respectively. Results were compared to a 6-MV photon beam doses in the range from 1–9 Gy with constant dose rate of 277 Gy/hr. The cell survival parameters from the linear quadratic (LQ) model were determined. Additionally, Monte Carlo simulations were performed to calculate the average dose, dose rate and the number of hits in the cell nucleus. For the HT29 cell line, which was the most radioresistant, the α/β ratio was found to be ≈ 31 for HDR–(90)Y and ≈ 3.5 for EBRT. LDR–(90)Y resulting in insignificant cell death compared to HDR–(90)Y and EBRT. Simulation results also showed for LDR–(90)Y, for doses ≲ 3 Gy, the average number of hits per cell nucleus is ≲ 2 indicating insufficiently delivered lethal dose. For (90)Y doses [Formula: see text] 3 Gy the number of hits per nucleus decreases rapidly and falls below ≈ 2 after ≈ 5 days of incubation time. Therefore, our results demonstrate that LDR–(90)Y is radiobiologically less effective than EBRT. However, HDR–(90)Y at ≈ 56 Gy was found to be radiobiologically as effective as acute ≈ 8 Gy EBRT. CONCLUSION: These results demonstrate that the efficacy of RNT is dependent on the initial dose rate at which radiation is delivered. Therefore, for a relatively long half-life radionuclide such as (90)Y, a higher initial activity is required to achieve an outcome as effective as EBRT. |
format | Online Article Text |
id | pubmed-6119681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-61196812018-09-20 Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro Gholami, Yaser H. Willowson, Kathy P. Forwood, Nicholas J. Harvie, Rozelle Hardcastle, Nicholas Bromley, Regina Ryu, HyunJu Yuen, Samuel Howell, Viive M. Kuncic, Zdenka Bailey, Dale L. EJNMMI Phys Original Research BACKGROUND: Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark (90)Y RNT (at different dose rates) against external beam radiotherapy (EBRT) in vitro and compare cell kill responses between the two irradiation processes. RESULTS: Three human colorectal carcinoma (CRC) cell lines (HT29, HCT116, SW48) were exposed to (90)Y doses in the ranges 1–10.4 and 6.2–62.3 Gy with initial dose rates of 0.013–0.13 Gy/hr (low dose rate, LDR) and 0.077–0.77 Gy/hr (high dose rate, HDR), respectively. Results were compared to a 6-MV photon beam doses in the range from 1–9 Gy with constant dose rate of 277 Gy/hr. The cell survival parameters from the linear quadratic (LQ) model were determined. Additionally, Monte Carlo simulations were performed to calculate the average dose, dose rate and the number of hits in the cell nucleus. For the HT29 cell line, which was the most radioresistant, the α/β ratio was found to be ≈ 31 for HDR–(90)Y and ≈ 3.5 for EBRT. LDR–(90)Y resulting in insignificant cell death compared to HDR–(90)Y and EBRT. Simulation results also showed for LDR–(90)Y, for doses ≲ 3 Gy, the average number of hits per cell nucleus is ≲ 2 indicating insufficiently delivered lethal dose. For (90)Y doses [Formula: see text] 3 Gy the number of hits per nucleus decreases rapidly and falls below ≈ 2 after ≈ 5 days of incubation time. Therefore, our results demonstrate that LDR–(90)Y is radiobiologically less effective than EBRT. However, HDR–(90)Y at ≈ 56 Gy was found to be radiobiologically as effective as acute ≈ 8 Gy EBRT. CONCLUSION: These results demonstrate that the efficacy of RNT is dependent on the initial dose rate at which radiation is delivered. Therefore, for a relatively long half-life radionuclide such as (90)Y, a higher initial activity is required to achieve an outcome as effective as EBRT. Springer International Publishing 2018-09-03 /pmc/articles/PMC6119681/ /pubmed/30175390 http://dx.doi.org/10.1186/s40658-018-0217-8 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Gholami, Yaser H. Willowson, Kathy P. Forwood, Nicholas J. Harvie, Rozelle Hardcastle, Nicholas Bromley, Regina Ryu, HyunJu Yuen, Samuel Howell, Viive M. Kuncic, Zdenka Bailey, Dale L. Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro |
title | Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro |
title_full | Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro |
title_fullStr | Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro |
title_full_unstemmed | Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro |
title_short | Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro |
title_sort | comparison of radiobiological parameters for (90)y radionuclide therapy (rnt) and external beam radiotherapy (ebrt) in vitro |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119681/ https://www.ncbi.nlm.nih.gov/pubmed/30175390 http://dx.doi.org/10.1186/s40658-018-0217-8 |
work_keys_str_mv | AT gholamiyaserh comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT willowsonkathyp comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT forwoodnicholasj comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT harvierozelle comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT hardcastlenicholas comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT bromleyregina comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT ryuhyunju comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT yuensamuel comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT howellviivem comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT kunciczdenka comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro AT baileydalel comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro |